Customer Service: 866-788-9007

Transforming the Management

of Dermatologic Cancers

Enabling More Accurate Treatment Plan Decisions With Our Line of
Gene Expression Profile (GEP) Tests

CUTANEOUS MELANOMA

Dx-Melanoma-2r
PROGNOSTIC

Predicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma

DiffDx-MelanomaStack-Color.svg
DIAGNOSTIC

A Highly Accurate and Objective Test Characterizing Difficult-to-Diagnose Melanocytic Lesions

SQUAMOUS CELL
CARCINOMA

Dx-Melanoma-1r1
PROGNOSTIC

Better Identifies Risk of Metastasis in Patients With One or More Risk Factors

UVEAL
MELANOMA

Dx-Melanoma-1r11
PROGNOSTIC

The Standard of Care for Evaluating Metastatic Risk in Uveal Melanoma

Scroll to Top